Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationCheol Whan Lee, Seung‐Jung Park, Seung‐Woon Rha et al.|Circulation|2013Cited by 281
Impact of the Stent Length on Long-Term Clinical Outcomes Following Newer-Generation Drug-Eluting Stent ImplantationIk Jun Choi, Ki‐Bae Seung, Yoon‐Seok Koh et al.|The American Journal of Cardiology|2013Cited by 50
Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary interventionMahn‐Won Park, Kiyuk Chang, Sung‐Ho Her et al.|Pharmacogenetics and Genomics|2013Cited by 18
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting StentJu-Youn Kim, Ki‐Bae Seung, Yunseok Choi et al.|Medicine|2015Cited by 5
AS-175: Predictive Factors of Procedural Success for Percutaneous Coronary Intervention of Chronic Total Occlusion: Lesion and Procedural CharacteristicsJae Hong Park, Kyu-Bo Choi, Hee-Yeol Kim et al.|The American Journal of Cardiology|2009Cited by 0